CDKN2A Antibody

• NCBI Gene ID:

  1029

• Swiss Prot:

  P42771

• Accession Number:

  NP_000068.1, NP_001182061.1

• Host:

  Goat

• Reactivity:

  Human

• Immunogen:

  The immunogen for this antibody is: C-HARIDAAEGPSDIPD

• Clonality:

  Polyclonal

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies

• Field of Research:

  Homeostasis, Signal Transduction, Cancer

• Purification:

  Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

• Positive Control:

  Cat. No. 1201 - HeLa Cell Lysate

• Concentration:

  500 ug/mL

• Buffer:

  Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.

• Modification:

  None

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Aliquot and store at -20˚ C. Minimize freezing and thawing.

• Specificity:

  This antibody is expected to recognise isoform p16INK4a (NP_000068.1) and isoform p16gamma (NP_001182061.1) .

• Applications Notes:

  Peptide ELISA: Western Blot:Immunohistochemistry:

• Symbol:

  CDKN2A

• NCBI Official Name:

  Cyclin-dependent kinase inhibitor 2A

• NCBI Organism:

  Homo sapiens

• Background Reference 01:

  Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol. 2005 Apr;72 (2) :115-22.

• Other Product Names:

  CDKN2A, p16INK4a, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), HGNC:1787, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p19 , CDK4 inhibitor p16-INK4, cell cycle negative regulator beta, cyclin-

• Tested Applications:

  ELISA, WB, IHC

• Protein ID:

  4502749

• Physical Properties:

  Liquid